p53 interferes with microtubule-stabilizing agent-induced apoptosis in prostate and colorectal cancer cells

Ji Young Kim1, Jin-Yong Chung, Seung Gee Lee

  • 1Department of Anatomy and Cell Biology, Dong-A University, Busan, Republic of Korea.

Insights

The tumor suppressor protein p53 inhibits docetaxel-induced apoptosis in prostate and colorectal cancers. Removing p53 enhances cancer cell sensitivity to this chemotherapy, suggesting new patient stratification strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Taxanes are crucial chemotherapy agents targeting microtubules in solid tumors.
  • The role of p53 in taxane resistance and cancer cell death remains unclear.
  • Understanding p53's influence is vital for optimizing taxane-based therapies.

Purpose of the Study:

  • To investigate the role of p53 in docetaxel-induced apoptosis in prostate and colorectal cancer cells.
  • To elucidate the signaling pathways, including caspases, involved in p53-mediated taxane resistance.
  • To determine if p53 status can predict patient response to docetaxel.

Main Methods:

  • Utilized p53-null, p53-mutant, and p53 wild-type prostate cancer cell lines (PC3, DU145, LNCaP).
  • Employed an isogenic pair of colorectal cancer cell lines (HCT-116 p53-/- and p53+/+).
  • Manipulated p53 levels through transient overexpression and gene knockdown.
  • Assessed docetaxel-induced apoptosis and caspase activity.

Main Results:

  • p53 significantly inhibited docetaxel-induced apoptosis in both prostate and colorectal cancer cells.
  • Apoptosis levels correlated inversely with p53 status: high in p53-null, intermediate in p53-mutant, and low in p53 wild-type cells.
  • Overexpression of p53 suppressed apoptosis, while p53 knockdown enhanced it.
  • Caspase activity was identified as a critical component in this p53-mediated process.

Conclusions:

  • p53 acts as a potent inhibitor of docetaxel-induced apoptosis in prostate and colorectal cancers.
  • Genetic or chemical knockout of p53 increases cancer cell sensitivity to docetaxel.
  • These findings suggest p53 status as a potential biomarker for stratifying patients for docetaxel-based chemotherapy regimens.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...